Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
3CL protease
Beaudette
avian coronavirus
coronavirus
infectious bronchitis virus
infectious clone
replicase
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
27 07 2022
27 07 2022
Historique:
pubmed:
22
7
2022
medline:
30
7
2022
entrez:
21
7
2022
Statut:
ppublish
Résumé
Infectious bronchitis virus (IBV) is an avian coronavirus that causes infectious bronchitis, an acute and highly contagious respiratory disease of chickens. IBV evolution under the pressure of comprehensive and widespread vaccination requires surveillance for vaccine resistance, as well as periodic vaccine updates. Reverse genetics systems are very valuable tools in virology, as they facilitate rapid genetic manipulation of viral genomes, thereby advancing basic and applied research. We report here the construction of an infectious clone of IBV strain Beaudette as a bacterial artificial chromosome (BAC). The engineered full-length IBV clone allowed the rescue of an infectious virus that was phenotypically indistinguishable from the parental virus. We used the infectious IBV clone and examined whether an enhanced green fluorescent protein (EGFP) can be produced by the replicase gene ORF1 and autocatalytically released from the replicase polyprotein through cleavage by the main coronavirus protease. We show that IBV tolerates insertion of the EGFP ORF at the 3' end of the replicase gene, between the sequences encoding nsp13 and nsp16 (helicase, RNA exonuclease, RNA endonuclease, and RNA methyltransferase). We further show that EGFP is efficiently cleaved from the replicase polyprotein and can be localized in double-membrane vesicles along with viral RNA polymerase and double-stranded RNA, an intermediate of IBV genome replication. One of the engineered reporter EGFP viruses were genetically stable during passage in cultured cells. We demonstrate that the reporter EGFP viruses can be used to study virus replication in host cells and for antiviral drug discovery and development of diagnostic assays.
Identifiants
pubmed: 35862676
doi: 10.1128/jvi.00653-22
pmc: PMC9327687
doi:
Substances chimiques
Polyproteins
0
RNA, Viral
0
enhanced green fluorescent protein
0
Green Fluorescent Proteins
147336-22-9
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0065322Références
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21
pubmed: 10805807
Trends Genet. 2000 Jun;16(6):254-9
pubmed: 10827452
J Virol. 2012 May;86(10):5808-16
pubmed: 22438542
J Virol. 2021 Jun 24;95(14):e0237420
pubmed: 33910954
Appl Microbiol Biotechnol. 2020 Oct;104(19):8427-8437
pubmed: 32813067
Sci Transl Med. 2020 Apr 29;12(541):
pubmed: 32253226
Methods Mol Biol. 2015;1282:135-52
pubmed: 25720478
J Virol. 2014 May;88(10):5319-27
pubmed: 24623413
Curr Biol. 1996 Mar 1;6(3):315-24
pubmed: 8805248
Curr Top Microbiol Immunol. 2005;287:133-59
pubmed: 15609511
PLoS Biol. 2020 Jun 8;18(6):e3000715
pubmed: 32511245
J Gen Virol. 1972 Sep;16(3):423-7
pubmed: 4627930
J Gen Virol. 2001 Jun;82(Pt 6):1273-1281
pubmed: 11369870
Nat Commun. 2020 Sep 4;11(1):4417
pubmed: 32887884
EMBO J. 1987 Dec 1;6(12):3779-85
pubmed: 3428275
Methods Mol Biol. 2017;1602:59-81
pubmed: 28508214
mBio. 2013 Oct 22;4(5):e00801-13
pubmed: 24149513
J Gen Virol. 2002 Mar;83(Pt 3):595-599
pubmed: 11842254
PLoS One. 2013 Jun 26;8(6):e67875
pubmed: 23840781
J Virol. 2013 Feb;87(4):2128-36
pubmed: 23221558
Methods Mol Biol. 2010;634:421-30
pubmed: 20677001
Virology. 2018 Jan 1;513:75-84
pubmed: 29035788
Cell Res. 2020 Aug;30(8):678-692
pubmed: 32541865
Avian Pathol. 2012;41(3):239-50
pubmed: 22702451
Curr Top Microbiol Immunol. 2005;287:199-227
pubmed: 15609513
Arch Virol. 1979;60(2):115-22
pubmed: 226034
Avian Pathol. 2005 Dec;34(6):439-48
pubmed: 16537157
J Virol. 2001 Dec;75(24):12359-69
pubmed: 11711626
Avian Dis. 2012 Dec;56(4):634-41
pubmed: 23397833
Virology. 2005 Feb 5;332(1):206-15
pubmed: 15661153
J Virol. 2004 Dec;78(24):13804-11
pubmed: 15564488
Nat Microbiol. 2021 Jan;6(1):11-18
pubmed: 33273742
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645453
Eur J Med Chem. 2018 Apr 25;150:334-346
pubmed: 29544147
J Virol. 2000 Nov;74(22):10600-11
pubmed: 11044104
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
J Virol. 2005 Oct;79(20):12742-51
pubmed: 16188977
J Virol Methods. 2009 Sep;160(1-2):48-56
pubmed: 19409420
J Virol. 2012 Nov;86(21):11754-62
pubmed: 22915796
J Gen Virol. 1987 Jan;68 ( Pt 1):57-77
pubmed: 3027249
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Commun. 2020 Aug 27;11(1):4282
pubmed: 32855413
Vet Res. 2007 Mar-Apr;38(2):281-97
pubmed: 17296157